Penny Stocks Archives - Page 1153 of 1231

1 minute read

Here’s Why Athenex Stock Is Getting Obliterated Thursday

August 11, 10:39 AM

Athenex Inc (NASDAQ: ATNX) shares are trading lower by 45.95% to $0.60 Thursday morning after the company announced a public offering valued at approximately $30 million.

ATNX

2 minute read

Zoned Properties Q2 Revenue Declines 9.3%, But Still Up 60% Over 6-Month Period: Here Are The Details

By Vuk Zdinjak

August 11, 10:38 AM

Zoned Properties, Inc. (OTCQB: ZDPY) Q2 2022 revenue was $498,652, a decrease of 9.3% compared to $550,064 in Q2 2021. Q2 2022 Financial Highlights

ZDPY

1 minute read

Momentus Shares Gain On Q2 Results

By Akanksha Bakshi

August 11, 9:58 AM

Momentus Inc (NASDAQ:MNTS) reported second-quarter revenue of $50 thousand and a gross margin of 76%. EPS loss was $(0.28), compared to…

MNTS

2 minute read

U.S. Stocks Trade Higher; Producer Prices Unexpectedly Decline In July

By Lisa Levin

August 11, 9:57 AM

U.S. stocks traded higher this morning, following the release of PPI data.

CRGY

1 minute read

Passage Bio Commences Initial-Stage Brain Disorder Study

By Ragothaman Srinivasan

August 11, 9:57 AM

Passage Bio (NASDAQ: PASG) has dosed the first patient in the global Phase 1/2 upliFT-D clinical trial evaluating PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin (GRN) mutations.

PASG

1 minute read

aTyr Pharma Shares Ascend As FDA Grants Fast Track Status To Lung Disease Candidate

By Ragothaman Srinivasan

August 11, 9:32 AM

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to aTyr Pharma’s (NASDAQ: LIFE) lead therapeutic candidate, efzofitimod (ATYR1923), for the treatment of pulmonary sarcoidosis, a major form of interstitial lung disease.

LIFE